Physician profile
Travis Mckellar
NPI 1538620851
$4,109.89
in general payments reported to CMS, 2019-2025
8 companies · $1,523 in 2025
The $1,523 reported for 2025 was more than what 78% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,467 · 2023: $432 · 2024: $687 · 2025: $1,523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,414 · Food and Beverage: $1,228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,414.40 |
| Food and Beverage | $1,228.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,807.11 | 2022-2025 | Prostep, Salvation, 7 X 23mm Citrelock Implant |
| Depuy Synthes Sales INC. | $184.30 | 2024-2025 | Motoband, Foot Osteotomy Wedge System, Minibunion |
| Linvatec Corporation | $27.92 | 2024 | Biobrace 23mm |
| Bioventus LLC | $24.86 | 2022 | |
| Integra Lifesciences Corporation | $17.25 | 2022 | |
| Smith+Nephew, INC. | $16.94 | 2024 | Stravix Pl, Grafix Pl |
| Mimedx Group, INC. | $16.07 | 2024 | |
| Treace Medical Concepts, INC. | $15.44 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Mckellar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.